Skip to content
Fast Company Executive Board

The Fast Company Executive Board is a private, fee-based network of influential leaders, experts, executives, and entrepreneurs who share their insights with our audience.

Plain language is healthcare’s next competitive advantage

AI is resetting the standards for communicating lab results, coverage, and treatments, and healthcare marketing must catch up.

[Photo: Getty Images]

Profile photo of Saul Marquez

CEO · Outcomes Rocket

For years, healthcare and medical device marketing have accepted a quiet compromise: scientific precision is the priority over simplicity. That trade-off is no longer tenable, and it is rapidly becoming a source of competitive disadvantage.

As AI-driven health experiences reshape how people consume and interpret information, clarity is no longer a secondary concern. It is the baseline expectation. The companies that gain an advantage over competitors over the next decade will not be the ones that explain more; they will be the ones that explain better.

AI HAS RESET THE STANDARD FOR “UNDERSTANDABLE”

With the introduction of ChatGPT Health, consumers now expect health information to arrive already interpreted, contextualized, and actionable. Increasingly, plain language is available on demand to explain lab results, symptoms, coverage decisions, and care pathways.

Just as important, these experiences pair clarity with explicit trust controls. OpenAI, for example, recently announced that ChatGPT Health (a dedicated space within ChatGPT designed specifically for health and wellness conversations) does not use chats, files, and memories to train foundation models, reinforcing transparency and consumer confidence.

The signal for health tech leaders is not the product itself. It’s what it represents. When targeted audiences can instantly receive clear explanations of complex health information, dense, acronym-heavy messaging no longer reads as “professional.” It reads as friction.

At that point, brands are no longer competing solely with peers. They are competing with clarity itself.

THE STRONGEST SIGNAL IS THE FORMAT

Our recent research analyzing 5,472 unique citations generated by multiple major chatbots in response to health-related prompts found that 59% emphasized consumer-friendly summaries or scientific interpretation rather than raw data. That pattern helps explain why translation and synthesis now dominate health discovery. In moments of uncertainty or stress, users gravitate toward sources that help them understand what this means and what to do next. Interpretation is now the value.

For marketing leaders, this represents a significant shift in competitive advantage. The market is moving from content volume to content comprehension. Organizations that reduce uncertainty quickly gain the most attention, trust, and conversions.

WHY PLAIN LANGUAGE PRODUCES AN ADVANTAGE

The industry typically frames plain language as a health literacy issue. While that is true, medical device and health tech executives should treat it as a growth and efficiency lever tied directly to four core business metrics.

  • Conversions improve because decision friction drops. Buying journeys in healthcare, whether patient-initiated or enterprise-driven, are rarely linear. Ambiguity around eligibility, indications, workflow fit, integration, reimbursement, or next steps causes hesitation. Clear language shortens decision cycles by making value and action explicit.
  • Cost-to-serve declines because confusion stops generating work. A large share of inbound calls and portal messages stems from basic comprehension failures. Each interaction adds labor, costs, delays care, and downstream rework. Plain language acts as upstream deflection, answering questions before they generate labor.
  • Trust strengthens because clarity signals integrity. In regulated markets, vague phrasing is often a defensive strategy. Ironically, it can erode trust. Clear, direct explanations, when paired with clinical rigor, signal transparency and credibility. Against AI-based benchmarks, unclear language is increasingly read as evasive rather than cautious.
  • Risk decreases because misunderstanding decreases. The industry sometimes dismisses plain language as “soft,” but consumer misunderstanding is a hard risk. Misunderstood instructions can cause clinical harm. Misread disclaimers can produce false confidence. Overstated marketing claims invite regulatory and reputational exposure. Plain language, when paired with clinical rigor, lowers the probability of misinterpretation while preserving accuracy.

TREAT PLAIN LANGUAGE AS INFRASTRUCTURE

Organizations do not realize sustained gains from clarity by editing copy ad hoc. Operationalizing plain language as infrastructure is a competitive advantage.

That starts with identifying high-friction moments: onboarding, implementation guidance, product limitations, integration requirements, reimbursement explanations, abnormal results, follow-up instructions, and financial discussions. These are the points where confusion stalls momentum and increases cost.

Effective teams govern clarity by defining reading-level targets by content type, maintaining approved glossaries, and standardizing structural formats. This ensures information is easy to scan and act on, across web, sales enablement, portals, and support materials.

Review processes should also be tiered by risk, not flattened. When all content flows through the same approval funnel, the result is often vague language that satisfies everyone and helps no one. Tiered review preserves speed for low-risk education while maintaining rigor for high-stakes claims.

Finally, clarity must be measured. Reduced follow-up contacts, higher completion rates, shorter sales cycles, and lower abandonment rates tie plain language directly to outcomes executives already prioritize. When clarity shows up in performance data, it becomes defensible in budget and strategy discussions.

A PRACTICAL CMO AGENDA FOR 2026

Treating plain language as a cross-functional growth initiative gives organizations a competitive edge.

The best place to start is wherever your funnel is already leaking. Look at signals that show where prospects are getting stuck, such as sales call notes, CRM activity, demo request drop-offs, cancellation or no-show reasons, and your highest-traffic product and solution pages.

Those areas reveal friction fast. You may be driving clicks and visits, but email engagement is flat, ads are underperforming, and your top pages are not turning interest into pipeline.

The same questions come up repeatedly. That’s a clarity problem. Reputation signals confusion, not clarity.

From there, alignment matters. The explanation on the website should match what appears in sales decks, implementation guides, customer portals, and follow-up communications. Consistent language builds confidence and accelerates action.

The ChatGPT Health experience noted earlier is a stark reminder that the future standard is information that is clear, contextual, and trustworthy by design. Organizations that respond will not do so by adding more content, disclaimers, or details. They will respond by making their materials effortless to understand.

If clarity is now the competitive baseline, the conclusion is straightforward. Medical device and health tech companies must stop treating plain language as a stylistic preference and start treating it as core infrastructure for growth, trust, and market relevance.

Saul Marquez is the CEO of Outcomes Rocket.